- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/24 - Oxygen atoms
Patent holdings for IPC class C07D 217/24
Total number of patents in this class: 464
10-year publication summary
|
35
|
35
|
39
|
32
|
42
|
39
|
22
|
34
|
25
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Quanticel Research, Inc. | 163 |
19 |
| Alcon, Inc. | 5425 |
18 |
| Bristol-myers Squibb Company | 4898 |
17 |
| Novartis AG | 10849 |
11 |
| Allergan, Inc. | 2349 |
9 |
| sanofi-aventis | 366 |
9 |
| Boehringer Ingelheim International GmbH | 4650 |
8 |
| Pfizer Inc. | 3387 |
8 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 163 |
7 |
| The University of Queensland | 660 |
7 |
| Genentech, Inc. | 3976 |
6 |
| NHWA Pharma. Corporation | 51 |
6 |
| AstraZeneca AB | 2909 |
5 |
| Arbutus Biopharma Corporation | 177 |
5 |
| BELLUS Health Inc. | 13 |
5 |
| Nerviano Medical Sciences S.r.l. | 256 |
5 |
| Resverlogix Corp. | 55 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 762 |
4 |
| Astellas Pharma Inc. | 1088 |
4 |
| Cytokinetics, Inc. | 277 |
4 |
| Other owners | 302 |